Management Team
Board of Directors

MonoSol Rx is a leading drug delivery company specializing in the development and commercialization of thin film pharmaceutical and over-the-counter (OTC) drug products. The Company’s thin film formulations offer significant patient benefits, including convenience, taste and potentially greater efficacy. Each thin film strip is small in size — about the size of a postage stamp, utilizes drug taste-masking technology and dissolves rapidly in the mouth without the need for water.

The Company currently has commercialized seven thin film formulations marketed in the U.S. and Canada.

In the prescription market, MonoSol Rx is currently developing thin film formulations with its pharmaceutical partners and through self-funded initiatives. The development programs are focused on approved drugs with expired or soon-to-be expired patents, thereby extending patent life and protecting drug revenues. The Company intends to grow its leadership position in thin film drug delivery through the continued development of its technology, manufacturing capabilities, strategic partnerships and intellectual property portfolio.

The Company has a vertically integrated development and production infrastructure housed at two state-of-the-art manufacturing facilities.